NINTEDANIB (NINTEDANIB ESILATE) — all Canadian products
10 DINs
10 marketed/approved
0 in shortage
Every Health Canada Drug Identification Number whose active ingredient is NINTEDANIB (NINTEDANIB ESILATE), with holder, form, strength and current status, compared weekly against the Drug Product Database.
| DIN | Product | Company | Form | Route | Strength | Status | Shortage |
|---|---|---|---|---|---|---|---|
| 02526891 | AURO-NINTEDANIB | AURO PHARMA INC | Capsule | Oral | NINTEDANIB (NINTEDANIB ESILATE) 100 MG | Marketed | |
| 02526905 | AURO-NINTEDANIB | AURO PHARMA INC | Capsule | Oral | NINTEDANIB (NINTEDANIB ESILATE) 150 MG | Marketed | |
| 02547511 | EUGIA-NINTEDANIB | EUGIA PHARMA INC. | Capsule | Oral | NINTEDANIB (NINTEDANIB ESILATE) 100 MG | Approved | |
| 02547538 | EUGIA-NINTEDANIB | EUGIA PHARMA INC. | Capsule | Oral | NINTEDANIB (NINTEDANIB ESILATE) 150 MG | Approved | |
| 02569248 | GLN-NINTEDANIB | GLENMARK PHARMACEUTICALS CANADA INC. | Capsule | Oral | NINTEDANIB (NINTEDANIB ESILATE) 150 MG | Approved | |
| 02569221 | GLN-NINTEDANIB | GLENMARK PHARMACEUTICALS CANADA INC. | Capsule | Oral | NINTEDANIB (NINTEDANIB ESILATE) 100 MG | Approved | |
| 02550849 | JAMP NINTEDANIB | JAMP PHARMA CORPORATION | Capsule | Oral | NINTEDANIB (NINTEDANIB ESILATE) 100 MG | Marketed | |
| 02540762 | JAMP NINTEDANIB | JAMP PHARMA CORPORATION | Capsule | Oral | NINTEDANIB (NINTEDANIB ESILATE) 150 MG | Marketed | |
| 02443074 | OFEV | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Capsule | Oral | NINTEDANIB (NINTEDANIB ESILATE) 150 MG | Marketed | |
| 02443066 | OFEV | BOEHRINGER INGELHEIM (CANADA) LTD LTEE | Capsule | Oral | NINTEDANIB (NINTEDANIB ESILATE) 100 MG | Marketed |
Browse other molecules: